iotrolan has been researched along with Conus Medullaris Syndrome in 1 studies
iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coutinho, C | 1 |
| McGeorge, A | 1 |
| Macpherson, P | 1 |
| Teasdale, E | 1 |
1 trial available for iotrolan and Conus Medullaris Syndrome
| Article | Year |
|---|---|
Iotrolan versus iopamidol for radiculography: a randomized double-blind study.
Topics: Clinical Trials as Topic; Contrast Media; Double-Blind Method; Female; Humans; Iodobenzoates; Iopami | 1988 |